Ted W. Love, See Remarks at Global Blood Therapeutics, Inc. (GBT), sold 159,477 shares at $81.85 ($13.1M) on 2020-01-22, disclosed to the SEC on 2020-01-23.
Open-market sale of $13.1M GBT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.98 | 29,311 | $2.4M | 18.4% |
| 2 | $81.98 | 29,311 | $2.4M | 18.4% |
| 3 | $82.78 | 10,166 | $842K | 6.4% |
| 4 | $82.78 | 10,166 | $842K | 6.4% |
| 5 | $83.56 | 523 | $44K | 0.3% |
| 6 | $81.01 | 6,819 |
| $552K |
| 4.2% |
| 7 | $81.01 | 6,819 | $552K | 4.2% |
| 8 | $81.85 | 32,150 | $2.6M | 20.1% |
| 9 | $81.85 | 32,150 | $2.6M | 20.1% |
| 10 | $82.45 | 1,031 | $85K | 0.7% |
| 11 | $82.45 | 1,031 | $85K | 0.7% |
| Total | $81.96 avg | 159,477 | $13.1M | 100% |
| Filing → |
| GBT | SELL | 2019-12-09 | $11.3M | — | Filing → |
| CASC | BUY | 2017-02-03 | $98K | — | Filing → |
| GBT | BUY | 2016-01-07 | $150K | — | Filing → |